These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16081506)

  • 21. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma gamma-globin gene expression suggests that fetal hematopoietic cells contribute to the pool of circulating cell-free fetal nucleic acids during pregnancy.
    Wataganara T; LeShane ES; Chen AY; Borgatta L; Peter I; Johnson KL; Bianchi DW
    Clin Chem; 2004 Apr; 50(4):689-93. PubMed ID: 15044329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.
    Go AT; Visser A; Mulders MA; Twisk JW; Blankenstein MA; van Vugt JM; Oudejans CB
    Prenat Diagn; 2007 Feb; 27(2):146-9. PubMed ID: 17186567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of plasma circulating mRNA analysis in cases of gestational trophoblastic disease.
    Masuzaki H; Miura K; Yamasaki K; Miura S; Yoshiura K; Yoshimura S; Nakayama D; Mapendano CK; Niikawa N; Ishimaru T
    Clin Chem; 2005 Jul; 51(7):1261-3. PubMed ID: 15860565
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening.
    Arcelli D; Farina A; Cappuzzello C; Bresin A; De Sanctis P; Perolo A; Prandstraller D; Valentini D; Zucchini C; Priori S; Rizzo N
    Prenat Diagn; 2010 Mar; 30(3):229-34. PubMed ID: 20063376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of biological factors influencing the placental mRNA profile in maternal plasma.
    Tsui NB; Wong CS; Chow KC; Lo ES; Cheng YK
    Prenat Diagn; 2014 Mar; 34(3):251-8. PubMed ID: 24352757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of cell-free RNA from maternal plasma.
    Zhong XY; Holzgreve W; Huang DJ
    Methods Mol Biol; 2008; 444():269-73. PubMed ID: 18425488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood.
    Okazaki S; Sekizawa A; Purwosunu Y; Iwasaki M; Farina A; Okai T
    J Med Genet; 2006 Sep; 43(9):e47. PubMed ID: 16950818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study.
    Tsui NB; Wong BC; Leung TY; Lau TK; Chiu RW; Lo YM
    Prenat Diagn; 2009 Nov; 29(11):1031-7. PubMed ID: 19650060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
    Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein production in term human placental tissue.
    Malek A; Bersinger NA; Di Santo S; Mueller MD; Sager R; Schneider H; Ghezzi F; Karousou E; Passi A; De Luca G; Raio L
    Placenta; 2006; 27(6-7):619-25. PubMed ID: 16026834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
    Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.
    Wong BC; Chan KC; Chan AT; Leung SF; Chan LY; Chow KC; Lo YM
    Clin Cancer Res; 2006 Apr; 12(8):2512-6. PubMed ID: 16638860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the placental epigenetic signature of the maspin gene in maternal plasma.
    Chim SS; Tong YK; Chiu RW; Lau TK; Leung TN; Chan LY; Oudejans CB; Ding C; Lo YM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14753-8. PubMed ID: 16203989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
    Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental mRNA in maternal plasma and its clinical application to the evaluation of placental status in a pregnant woman with placenta previa-percreta.
    Masuzaki H; Miura K; Yoshiura K; Yamasaki K; Miura S; Yoshimura S; Nakayama D; Mapendano CK; Niikawa N; Ishimaru T
    Clin Chem; 2005 May; 51(5):923-5. PubMed ID: 15855676
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxidative stress alters the integrity of cell-free mRNA fragments associated with placenta-derived syncytiotrophoblast microparticles.
    Rusterholz C; Holzgreve W; Hahn S
    Fetal Diagn Ther; 2007; 22(4):313-7. PubMed ID: 17361087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.